Innate Pharma
(IPHYF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPHYF | SRZN | GALT | ||
| Company | Innate Pharma | Consonance-Hfw Acq Corp | Galectin Therapeutic | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 2.1550 | 22.21 | 2.73 | ||
| High | 2.1550 | 23.03 | 2.88 | ||
| Low | 2.1550 | 21.80 | 2.68 | ||
| Latest | 2.1550 | 22.83 | 2.76 | ||
| Change | +0.2500 | +0.69 | +0.04 | ||
| % Change | +13.12% | +3.14% | +1.47% | ||
| Volume | 100 | 73,000 | 328,500 | ||
| 20-Day Average Volume | N/A | 153,205 | 326,760 | ||
| Previous Close | 1.9050 | 22.14 | 2.72 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 21.20 | 3.03 | ||
| 20-Day Raw Stochastic | N/A | 65.19% | 15.79% | ||
| 20-Day Relative Strength | N/A | 56.13 | 37.08 | ||
| Weighted Alpha | N/A | +107.78 | +21.11 | ||
| Today's Opinion | N/A | 100% Buy | 72% Sell | ||
| Previous Opinion | N/A | 100% Buy | 72% Sell | ||
| Last Month's Opinion | N/A | 80% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.75% since 09/12/25 | -1.06% since 02/03/26 | -15.08% since 02/03/26 | ||
| Low | 1.9050 on 12/09/25 | 21.07 on 02/06/26 | 2.61 on 02/09/26 | ||
| High | 2.1550 on 12/16/25 | 25.47 on 02/05/26 | 3.23 on 02/04/26 | ||
| 1-Month | |||||
| %Chg | +7.75% since 10/02/25 | +23.50% since 01/09/26 | -12.38% since 01/09/26 | ||
| Low | 1.9050 on 12/09/25 | 16.75 on 01/12/26 | 2.61 on 02/09/26 | ||
| High | 2.1550 on 12/16/25 | 25.47 on 02/05/26 | 3.56 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +7.75% since 09/12/25 | +93.52% since 11/10/25 | -46.92% since 11/10/25 | ||
| Low | 1.9050 on 12/09/25 | 11.73 on 11/11/25 | 2.61 on 02/09/26 | ||
| High | 2.1550 on 12/16/25 | 25.47 on 02/05/26 | 7.13 on 12/17/25 | ||
| 6-Month | |||||
| %Chg | +24.21% since 06/12/25 | +138.86% since 08/08/25 | -33.49% since 08/08/25 | ||
| Low | 1.3100 on 07/07/25 | 9.55 on 08/11/25 | 2.61 on 02/09/26 | ||
| High | 2.1550 on 12/16/25 | 25.47 on 02/05/26 | 7.13 on 12/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 180,654 | 189,771 | 175,367 | ||
| Shares Outstanding, K | 83,830 | 8,571 | 64,473 | ||
| Annual Sales | 21,770,000 | 10,660,000 | 0 | ||
| Annual Net Income | -53,530,000 | -63,560,000 | -47,050,000 | ||
| Last Quarter Sales | N/A | 980,000 | 0 | ||
| Last Quarter Net Income | N/A | -71,640,000 | -8,180,000 | ||
| 60-Month Beta | -0.04 | 0.58 | 1.00 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -3.61 on 11/07/25 | -0.13 on 11/14/25 | ||
| Latest Earnings Date | 03/26/26 | 03/30/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||